Syneron's Elure(TM) Advanced Dermal Whitening Product Line Wins The Prestigious International Technology Award In The New Technology Launch Category
YOKNEAM, Israel, April 16 /PRNewswire-FirstCall/ -- Syneron Medical Ltd. (Nasdaq: ELOS), an innovator in the development, marketing and sales of elos™ combined-energy medical aesthetic devices, won first place in Cosmetics & Toiletries (C&T) magazine's 5th International Technology Award presented at the In-Cosmetic show in Paris, France. This prestigious award recognized the launch of Syneron's elure™ Advanced Dermal Whitening product and its significance within the cosmetic R&D industry.
The elure™ Advanced Dermal Whitening product line is the first scientifically proven enzymatic skin whitening treatment that utilizes a unique scientific discovery of a naturally occurring bio-active substance called Melanozyme ™. Melanozyme acts to immediately target and disintegrate the melanin to diminish dark colored pigment in the skin safely, with virtually no side effects. Unlike many other whitening products on the market, the elure product line does not contain Hydroquinone, which has been reported to cause side effects such as skin redness and burning sensations. In addition, while other skin whitening products inhibit the formation of melanin, elure acts to target and disintegrate melanin resulting in a much faster whitening effect. elure™ Advanced Dermal Whitening was introduced in November 2009 at the world renowned cosmetic show in Asia, Cosmoprof Hong Kong. The "TRY IT ON THE SPOT" campaign captivated the audience as they observed first hand the dramatic effect of elure on melanin. Once elure was applied, the melanin decomposed "on the spot".
C&T magazine received a record breaking 57 entries in total for the 2010 awards. These entries were judged by a panel of twelve experts in cosmetics R&D to arrive at the six finalists. Syneron's elure was nominated one of the three finalists, and then the winner of the New Technology Launch Category Award for 2010. "We are very pleased with the recognition that RBT and Syneron got by this award," said Dr. Shimon Eckhouse, Chairman of Syneron Medical. "The great work performed by the elure team resulted in this significant achievement, which is part of our long term strategy to offer the most advanced and effective technology to the global aesthetic market."
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV